↓ Skip to main content

Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic

Overview of attention for article published in Frontiers in Pharmacology, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gene Therapy for Cystic Fibrosis Lung Disease: Overcoming the Barriers to Translation to the Clinic
Published in
Frontiers in Pharmacology, November 2018
DOI 10.3389/fphar.2018.01381
Pubmed ID
Authors

Martin Donnelley, David W. Parsons

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 121 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 17%
Student > Ph. D. Student 15 12%
Student > Master 15 12%
Researcher 8 7%
Other 7 6%
Other 9 7%
Unknown 46 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 22 18%
Medicine and Dentistry 13 11%
Agricultural and Biological Sciences 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Nursing and Health Professions 3 2%
Other 21 17%
Unknown 45 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#7,833,677
of 24,293,076 outputs
Outputs from Frontiers in Pharmacology
#3,477
of 18,210 outputs
Outputs of similar age
#153,739
of 445,957 outputs
Outputs of similar age from Frontiers in Pharmacology
#103
of 386 outputs
Altmetric has tracked 24,293,076 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 18,210 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,957 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 386 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.